Citation: Anman Zhang, Luo Hai, Tianzheng Wang, Hong Cheng, Man Li, Xiaoxiao He, Kemin Wang. NIR-triggered drug delivery system based on phospholipid coated ordered mesoporous carbon for synergistic chemo-photothermal therapy of cancer cells[J]. Chinese Chemical Letters, ;2020, 31(12): 3158-3162. doi: 10.1016/j.cclet.2020.04.035 shu

NIR-triggered drug delivery system based on phospholipid coated ordered mesoporous carbon for synergistic chemo-photothermal therapy of cancer cells

State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Biology, College of Chemistry and Chemical Engineering, Hunan University, State Key Laboratory for Bio-Nanotechnology and Molecular Engineering of Hunan Province, Changsha 410082, China

xiaoxiaohe@hnu.edu.cn

kmwang@hnu.edu.cn

Received Date: 4 March 2020
Revised Date: 20 April 2020
Accepted Date: 21 April 2020
Available Online: 24 April 2020

Figures(4)

Chemo-photothermal treatment is one of the most efficient strategies for cancer therapy. However, traditional drug carriers without near-infrared absorption capacity need to be loaded with materials behaving photothermal properties, as it results in complicated synthesis process, inefficient photothermal effects and hindered NIR-mediated drug release. Herein we report a facile synthesis of a polyethylene glycol (PEG) linked liposome (PEG-liposomes) coated doxorubicin (DOX)-loaded ordered mesoporous carbon (OMC) nanocomponents (PEG-LIP@OMC/DOX) by simply sonicating DOX and OMC in PEG-liposomes suspensions. The as-obtained PEG-LIP@OMC/DOX exhibits a nanoscale size (600±15 nm), a negative surface potential (-36.70 mV), high drug loading (131.590 mg/g OMC), and excellent photothermal properties. The PEG-LIP@OMC/DOX can deliver loaded DOX to human MCF-7 breast cancer cells (MCF-7) and the cell toxicity viability shows that DOX unloaded PEG-LIP@OMC has no cytotoxicity, confirming the PEG-LIP@OMC itself has excellent biocompatibility. The NIR-triggered release studies demonstrate that this NIR-responsive drug delivery system enables on-demand drug release. Furthermore, cell viability results using human MCF-7 cells demonstrated that the combination of NIR-based hyperthermal therapy and triggered chemotherapy can provide higher therapeutic efficacy than respective monotherapies. With these excellent features, we believe that this phospholipid coating based multifunctional delivery system strategy should promote the application of OMC in nanomedical applications.
1. [1]
  A. Vinu, T. Mori, K. Ariga, Sci. Technol. Adv. Mat. 7(2006) 753-771. doi: 10.1016/j.stam.2006.10.007
2. [2]
  N.D. Petkovich, A. Stein, Chem. Soc. Rev. 42(2013) 3721-3739. doi: 10.1039/C2CS35308C
3. [3]
  C.Y. Hong, X. Li, C.Y. Pan, J. Mater. Chem. 19(2009) 5155-5160. doi: 10.1039/b820534e
4. [4]
  Q. Gao, Y. Xu, D. Wu, et al., J. Phys. Chem. C 113(2009) 12753-12758. doi: 10.1021/jp9043978
5. [5]
  N.K. Mal, M. Fujiwara, Y. Tanaka, Nature 421(2003) 350-353. doi: 10.1038/nature01362
6. [6]
  N.K. Mal, M. Fujiwara, Y. Tanaka, et al., Chem. Mater. 15(2003) 3385-3394. doi: 10.1021/cm0343296
7. [7]
  Y.Z. You, K.K. Kalebaila, S.L. Brock, et al., Chem. Mater. 20(2008) 3354-3359. doi: 10.1021/cm703363w
8. [8]
  A. Schlossbauer, S. Warncke, P.M.E. Gramlich, et al., Angew. Chem. Int. Ed. 49(2010) 4734-4737. doi: 10.1002/anie.201000827
9. [9]
  H. Kim, S. Kim, C. Park, et al., Adv. Mater. 22(2010) 4280-4283. doi: 10.1002/adma.201001417
10. [10]
  Z. Luo, K. Cai, Y. Hu, et al., Angew. Chem. Int. Ed. 50(2011) 640-643. doi: 10.1002/anie.201005061
11. [11]
  C.L. Zhu, C.H. Lu, X.Y. Song, et al., Angew. Chem. Int. Ed. 130(2008) 2382-2383.
12. [12]
  K. Patel, S. Angelos, W.R. Dichtel, et al., J. Am. Chem. Soc. 130(2008) 2382-2383. doi: 10.1021/ja0772086
13. [13]
  F. Lu, J.F. Wang, L. Yang, et al., Chem. Commun. 51(2015) 9447-9450. doi: 10.1039/C5CC01725D
14. [14]
  G.X. Yang, R.C. Lv, F. He, et al., Nanoscale 7(2015) 13747-13758. doi: 10.1039/C5NR03085D
15. [15]
  X.J. Liu, F.F. Fu, K.B. Xu, et al., J. Mater. Chem. B 2(2014) 5358-5367. doi: 10.1039/c4tb00919c
16. [16]
  K.Y. Wang, H. Yao, Y. Meng, et al., Acta Biomater. 16(2015) 196-205. doi: 10.1016/j.actbio.2015.01.002
17. [17]
  Q.J. He, Y. Gao, L.X. Zhang, et al., Biomaterials 32(2011) 7711-7720. doi: 10.1016/j.biomaterials.2011.06.066
18. [18]
  Q.J. He, Z.W. Zhang, Y. Gao, et al., Small 5(2009) 2722-2729. doi: 10.1002/smll.200900923
19. [19]
  Y. Wang, K.Y. Wang, X.Y. Yan, et al., Adv. Healthc. Mater. 3(2014) 485-489. doi: 10.1002/adhm.201300324
20. [20]
  L. Chen, H. Zhang, J. Zheng, et al., Mater. Sci. Eng. C 84(2018) 21-31.
21. [21]
  S. Wang, C.Y. Li, Y. Meng, et al., ACS Biomater. Sci. Eng. 3(2017) 1702-1709. doi: 10.1021/acsbiomaterials.7b00326
22. [22]
  H.L. Li, J.M. Li, X.Y. He, et al., Chin. Chem. Lett. 30(2019) 1083-1088. doi: 10.1016/j.cclet.2019.01.003
23. [23]
  Y. Song, D. Li, J.L. He, et al., Chin. Chem. Lett. 30(2019) 2027-2031. doi: 10.1016/j.cclet.2019.04.052
24. [24]
  X. Duan, X. Yang, C.L. Dai, et al., Mater. Express 9(2019) 757-763. doi: 10.1166/mex.2019.1552
25. [25]
  J.K. Kundu, Y.J. Surh, Cancer Lett. 269(2008) 243-261. doi: 10.1016/j.canlet.2008.03.057
26. [26]
  M. Chen, S.N. Yang, X.X. He, et al., J. Mater. Chem. B 2(2014) 6064-6071.
27. [27]
  Q.Y. Li, C.G. Zhou, Z. Ji, et al., J. Mater. Chem. A 3(2015) 7241-7247. doi: 10.1039/C4TA06083K
28. [28]
  P. Selvam, B. Kuppan, Catal. Today 198(2012) 85-91. doi: 10.1016/j.cattod.2012.06.033
29. [29]
  S. Jun, S.H. Joo, R. Ryoo, et al., J. Am. Chem. Soc. 122(2000) 10712-10713.
30. [30]
  S.C. Qi, Y. Liu, A.Z. Peng, et al., Chem. Eng. J. 361(2019) 945-952.
31. [31]
  B. He, F.J. Liu, S.K. Yan, et al., J. Mater. Chem. A 5(2017) 18064-18070.
32. [32]
  J.J. Ma, P.J. Li, W.W. Wang, et al., ACS Nano 12(2018) 9022-9032.
1. [1]
  Xinran Xi , Xiyu Wang , Ziyue Xi , Chuanyong Fan , Yingying Jiang , Zhenhua Li , Lu Xu . Facile GSH responsive glycyrrhetinic acid conjunction for liver targeting therapy. Chinese Chemical Letters, 2025, 36(10): 110773-. doi: 10.1016/j.cclet.2024.110773
2. [2]
  Ting Zhang , Deqiang Chen , Ningzhi Zhang , Mingxu Zhang , Qiang Huang , Wei Liu , Ran Gao , Yong Zhang . Self-assembled supramolecular nanofibers integrate pH-responsive drug delivery and antimicrobial for combined cancer therapy. Chinese Chemical Letters, 2026, 37(2): 111117-. doi: 10.1016/j.cclet.2025.111117
3. [3]
  Min Zhang , Ye Chen , Yanan Li , Yifan Zhao , Bai Lv , Jie Cao , Bing Yu , Hailin Cong . Manipulating extracellular matrix to enhance intratumor drug delivery for nanomaterial-based photothermal therapy. Chinese Chemical Letters, 2025, 36(12): 111588-. doi: 10.1016/j.cclet.2025.111588
4. [4]
  Jing Feng , Yanhong Liu , Liming Gong , Chenfei Liu , Congcong Xiao , Liqing Chen , Mingji Jin , Zhonggao Gao , Wei Huang , Yubo Li . Recent progress on drug delivery systems of regulating intratumoral bacteria for tumor therapy. Chinese Chemical Letters, 2025, 36(11): 110907-. doi: 10.1016/j.cclet.2025.110907
5. [5]
  Yan Yu , Cailing Gan , Kun Shi , Zhongwu Bei , Yang Yu , Meng Pan , Hanzhi Deng , Zhiyong Qian . Recent advances in drug delivery systems for pulmonary fibrosis therapy. Chinese Chemical Letters, 2026, 37(1): 111596-. doi: 10.1016/j.cclet.2025.111596
6. [6]
  Yiyao Wan , Wen Chen , Yan Yu , Meng Pan , Kun Shi , Zhiyong Qian . Biomaterial-based drug delivery systems for the therapy of malignant pleural effusion. Chinese Chemical Letters, 2026, 37(1): 111513-. doi: 10.1016/j.cclet.2025.111513
7. [7]
  Shengyi Gong , Guoqiang Feng . Visible light-triggered NIR ratiometric fluorescent metal-free CO-releasing molecule for self-monitoring of CO delivery and effective cancer therapy. Chinese Chemical Letters, 2025, 36(7): 110409-. doi: 10.1016/j.cclet.2024.110409
8. [8]
  Ningyue Xu , Jun Wang , Lei Liu , Changyang Gong . Injectable hydrogel-based drug delivery systems for enhancing the efficacy of radiation therapy: A review of recent advances. Chinese Chemical Letters, 2024, 35(8): 109225-. doi: 10.1016/j.cclet.2023.109225
9. [9]
  Zhilong Xie , Guohui Zhang , Ya Meng , Yefei Tong , Jian Deng , Honghui Li , Qingqing Ma , Shisong Han , Wenjun Ni . A natural nano-platform: Advances in drug delivery system with recombinant high-density lipoprotein. Chinese Chemical Letters, 2024, 35(11): 109584-. doi: 10.1016/j.cclet.2024.109584
10. [10]
  Linghui Zou , Meng Cheng , Kaili Hu , Jianfang Feng , Liangxing Tu . Vesicular drug delivery systems for oral absorption enhancement. Chinese Chemical Letters, 2024, 35(7): 109129-. doi: 10.1016/j.cclet.2023.109129
11. [11]
  Fengjie Liu , Fansu Meng , Zhenjiang Yang , Huan Wang , Yuehong Ren , Yu Cai , Xingwang Zhang . Exosome-biomimetic nanocarriers for oral drug delivery. Chinese Chemical Letters, 2024, 35(9): 109335-. doi: 10.1016/j.cclet.2023.109335
12. [12]
  Jiechen Liu , Xiaoguang Li , Ruiyang Xia , Yuqi Wang , Fenghe Zhang , Yongzhi Pang , Qing Li . Efficient suppression of oral squamous cell carcinoma through spatial dimension conversion drug delivery systems-enabled immunomodulatory-photodynamic therapy. Chinese Chemical Letters, 2024, 35(12): 109619-. doi: 10.1016/j.cclet.2024.109619
13. [13]
  Yujie Li , Ya-Nan Wang , Yin-Gen Luo , Hongcai Yang , Jinrui Ren , Xiao Li . Advances in synthetic biology-based drug delivery systems for disease treatment. Chinese Chemical Letters, 2024, 35(11): 109576-. doi: 10.1016/j.cclet.2024.109576
14. [14]
  Guanlong Li , Zhuoyan Li , Yan Sun , Tiange Bu , Shaochuan Chen , Leixin Yang , Zhi Li , Wenyue Mao , Yanpeng Jia . Advances in CNS drug delivery strategies to cross the blood-brain barrier. Chinese Chemical Letters, 2026, 37(1): 111524-. doi: 10.1016/j.cclet.2025.111524
15. [15]
  Haijun Shen , Yi Qiao , Chun Zhang , Yane Ma , Jialing Chen , Yingying Cao , Wenna Zheng . A matrix metalloproteinase-sensitive hydrogel combined with photothermal therapy for transdermal delivery of deferoxamine to accelerate diabetic pressure ulcer healing. Chinese Chemical Letters, 2024, 35(12): 110283-. doi: 10.1016/j.cclet.2024.110283
16. [16]
  Wei Zhou , Di He , Ning Liu , Ying Li , Wenzhao Han , Weiping Zhou , Siyu Zhang , Cong Yu . A PDI-based NIR-Ⅱ fluorescence imaging guided molecular phototheranostic platform for GSH-triggered gas therapy, mild photothermal therapy and NIR-activated photodynamic therapy. Chinese Chemical Letters, 2025, 36(11): 110854-. doi: 10.1016/j.cclet.2025.110854
17. [17]
  Linjie Ju , Zhongxi Huang , Qian Shen , Chan Fu , Shuanghe Li , Wenjie Duan , Chenfeng Xu , Weizhen An , Zhiqiang Zhai , Jifu Wei , Changmin Yu , Guoren Zhou . Glutathione depletion based Pt(Ⅳ) hybrid mesoporous organosilica delivery system to conquer cisplatin chemoresistance: A “one stone three birds” strategy. Chinese Chemical Letters, 2024, 35(10): 109450-. doi: 10.1016/j.cclet.2023.109450
18. [18]
  Mingrui Zhang , Lingyu Jin , Yuda Zhu , Junfeng Kou , Bo Liu , Jing Chen , Xiaolin Zhong , Xianghua Wu , Junfeng Zhang , Wenxiu Ren . A near-infrared Ⅱ fluorescent dye based on oxanthracene: Real-time imaging of drug-induced acute liver injury and photothermal therapy for tumor. Chinese Chemical Letters, 2025, 36(10): 110772-. doi: 10.1016/j.cclet.2024.110772
19. [19]
  Lizhuang Zhong , Ming Liu , Shilong Su , Dongxin Zeng , Jing Hu , Zhiqian Guo . Engineering stimuli-responsive block copolymers for multimodal bioimaging. Chinese Chemical Letters, 2026, 37(1): 111512-. doi: 10.1016/j.cclet.2025.111512
20. [20]
  Zhaomin Tang , Qian He , Jianren Zhou , Shuang Yan , Li Jiang , Yudong Wang , Chenxing Yao , Huangzhao Wei , Keda Yang , Jiajia Wang . Active-transporting of charge-reversal Cu(Ⅱ)-doped mesoporous silica nanoagents for antitumor chemo/chemodynamic therapy. Chinese Chemical Letters, 2024, 35(7): 109742-. doi: 10.1016/j.cclet.2024.109742

Get Citation

PDF

XML

Metrics

PDF Downloads(14)
Abstract views(1906)
HTML views(186)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142